Pacific Biosciences of California (PACB) Competitors $0.94 -0.04 (-4.05%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$0.96 +0.02 (+1.65%) As of 05:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACB vs. HBIO, TMO, A, MTD, WAT, ILMN, TECH, BIO, CRL, and BRKRShould you be buying Pacific Biosciences of California stock or one of its competitors? The main competitors of Pacific Biosciences of California include Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), and Bruker (BRKR). These companies are all part of the "life sciences tools & services" industry. Pacific Biosciences of California vs. Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Charles River Laboratories International Bruker Pacific Biosciences of California (NASDAQ:PACB) and Harvard Bioscience (NASDAQ:HBIO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation. Do analysts rate PACB or HBIO? Pacific Biosciences of California presently has a consensus target price of $2.34, indicating a potential upside of 148.42%. Harvard Bioscience has a consensus target price of $3.00, indicating a potential upside of 808.54%. Given Harvard Bioscience's higher possible upside, analysts plainly believe Harvard Bioscience is more favorable than Pacific Biosciences of California.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pacific Biosciences of California 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Harvard Bioscience 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals & insiders have more ownership in PACB or HBIO? 80.9% of Harvard Bioscience shares are held by institutional investors. 2.5% of Pacific Biosciences of California shares are held by company insiders. Comparatively, 9.0% of Harvard Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is PACB or HBIO more profitable? Harvard Bioscience has a net margin of -14.57% compared to Pacific Biosciences of California's net margin of -200.40%. Harvard Bioscience's return on equity of -4.64% beat Pacific Biosciences of California's return on equity.Company Net Margins Return on Equity Return on Assets Pacific Biosciences of California-200.40% -42.89% -14.77% Harvard Bioscience -14.57%-4.64%-2.40% Does the media prefer PACB or HBIO? In the previous week, Pacific Biosciences of California had 5 more articles in the media than Harvard Bioscience. MarketBeat recorded 5 mentions for Pacific Biosciences of California and 0 mentions for Harvard Bioscience. Pacific Biosciences of California's average media sentiment score of 0.09 beat Harvard Bioscience's score of 0.00 indicating that Pacific Biosciences of California is being referred to more favorably in the media. Company Overall Sentiment Pacific Biosciences of California Neutral Harvard Bioscience Neutral Which has higher earnings and valuation, PACB or HBIO? Harvard Bioscience has lower revenue, but higher earnings than Pacific Biosciences of California. Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Harvard Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPacific Biosciences of California$152.36M1.85-$308.65M-$2.79-0.34Harvard Bioscience$91.40M0.16-$3.41M-$1.32-0.25 Does the MarketBeat Community prefer PACB or HBIO? Pacific Biosciences of California received 84 more outperform votes than Harvard Bioscience when rated by MarketBeat users. However, 71.15% of users gave Harvard Bioscience an outperform vote while only 66.37% of users gave Pacific Biosciences of California an outperform vote. CompanyUnderperformOutperformPacific Biosciences of CaliforniaOutperform Votes45466.37% Underperform Votes23033.63% Harvard BioscienceOutperform Votes37071.15% Underperform Votes15028.85% Which has more volatility & risk, PACB or HBIO? Pacific Biosciences of California has a beta of 2.19, indicating that its stock price is 119% more volatile than the S&P 500. Comparatively, Harvard Bioscience has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. SummaryPacific Biosciences of California and Harvard Bioscience tied by winning 9 of the 18 factors compared between the two stocks. Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACB vs. The Competition Export to ExcelMetricPacific Biosciences of CaliforniaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$282.53M$4.31B$5.33B$8.39BDividend YieldN/A0.58%5.21%4.11%P/E Ratio-0.5726.7026.7919.70Price / Sales1.853.77393.69121.79Price / CashN/A36.1738.2534.62Price / Book0.361.546.774.50Net Income-$308.65M-$84.30M$3.23B$248.22M7 Day Performance-9.03%1.92%0.42%-0.80%1 Month Performance-19.18%2.47%9.06%11.52%1 Year Performance-51.47%-20.32%18.55%8.99% Pacific Biosciences of California Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACBPacific Biosciences of California1.5904 of 5 stars$0.94-4.0%$2.34+148.4%-49.1%$282.53M$152.36M-0.57730HBIOHarvard Bioscience3.6194 of 5 stars$0.35+11.8%$4.50+1,178.0%-90.0%$15.57M$94.14M-1.07490Analyst ForecastHigh Trading VolumeTMOThermo Fisher Scientific4.9932 of 5 stars$432.16+7.2%$607.43+40.6%-32.3%$163.14B$42.90B26.14130,000Trending NewsDividend AnnouncementAnalyst UpgradeAnalyst RevisionAAgilent Technologies4.8366 of 5 stars$115.53+8.0%$143.00+23.8%-28.2%$32.94B$6.51B26.5617,900Trending NewsUpcoming EarningsDividend AnnouncementAnalyst ForecastMTDMettler-Toledo International4.4721 of 5 stars$1,175.33+8.7%$1,296.13+10.3%-24.4%$24.43B$3.83B29.0018,000News CoveragePositive NewsAnalyst UpgradeWATWaters3.9387 of 5 stars$366.80+6.6%$390.19+6.4%-0.2%$21.83B$2.98B34.258,200Trending NewsAnalyst UpgradeILMNIllumina4.8012 of 5 stars$81.57+7.7%$130.95+60.5%-25.0%$12.91B$4.37B-10.6211,500Positive NewsAnalyst ForecastTECHBio-Techne4.8427 of 5 stars$53.90+7.9%$73.44+36.3%-43.0%$8.52B$1.21B54.443,000Positive NewsDividend AnnouncementHigh Trading VolumeBIOBio-Rad Laboratories4.7973 of 5 stars$254.32+6.6%$327.40+28.7%-22.1%$7.12B$2.54B-3.918,200Positive NewsCRLCharles River Laboratories International4.9025 of 5 stars$143.06+3.1%$176.00+23.0%-38.2%$7.03B$4.02B953.7121,400Positive NewsBRKRBruker4.9301 of 5 stars$40.26+7.3%$60.10+49.3%-53.6%$6.10B$3.37B52.978,520Dividend AnnouncementAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies HBIO Competitors TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors TECH Competitors BIO Competitors CRL Competitors BRKR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PACB) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.